{
  "id": 18147665,
  "title": "Biopharma likely to climb higher after ‘blue wave,’ analysts say",
  "url": "https://urgent.news/2026/11/04/biopharma-likely-to-climb-higher-after-blue-wave-analysts-say",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T15:28:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/biotech-pharma-midterm-elections-impact/873667/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Historical data suggests the sector outperforms after midterm elections. And Democrats, newly in control of Congress, have “bigger fish to fry” than drug pricing, analysts said.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}